Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah L Steinberg-Vorhoff

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|February 26, 2025
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)Hannah L Steinberg-Vorhoff, Andriana Tropotel, Jens M Theysohn, et al.
Radiology and Oncology|November 28, 2024
Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastasesSebastian Zensen, Hannah L Steinberg-Vorhoff, Aleksandar Milosevic, et al.
Liver Cancer|January 23, 2026
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with BevacizumabMatthias Jeschke, Julia M Schütte, Stephan Himmen, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 28, 2025
Degradable Starch Microsphere Transarterial Chemoembolization as Salvage Therapy in Patients with Uveal Melanoma Liver MetastasesHannah L Steinberg-Vorhoff, Johannes Haubold, Sebastian Bauer, et al.
European Journal of Radiology Open|February 2, 2026
Muscle and fat matter: Automated CT-based body composition analysis predicts survival in <i>Hepatocellular carcinoma</i> patients undergoing radioembolizationHannah L Steinberg-Vorhoff, Anneke Ketelsen, Tabea Schuch, et al.
Journal of Medical Imaging and Radiation Oncology|September 24, 2024
Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?Hannah L Steinberg-Vorhoff, Saskia C Ting, Sebastian Zensen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|February 26, 2025
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE)Hannah L Steinberg-Vorhoff, Andriana Tropotel, Jens M Theysohn, et al.
Radiology and Oncology|November 28, 2024
Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastasesSebastian Zensen, Hannah L Steinberg-Vorhoff, Aleksandar Milosevic, et al.
Liver Cancer|January 23, 2026
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with BevacizumabMatthias Jeschke, Julia M Schütte, Stephan Himmen, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 28, 2025
Degradable Starch Microsphere Transarterial Chemoembolization as Salvage Therapy in Patients with Uveal Melanoma Liver MetastasesHannah L Steinberg-Vorhoff, Johannes Haubold, Sebastian Bauer, et al.
European Journal of Radiology Open|February 2, 2026
Muscle and fat matter: Automated CT-based body composition analysis predicts survival in <i>Hepatocellular carcinoma</i> patients undergoing radioembolizationHannah L Steinberg-Vorhoff, Anneke Ketelsen, Tabea Schuch, et al.
Journal of Medical Imaging and Radiation Oncology|September 24, 2024
Are histomorphological patterns a predictor for survival in uveal melanoma patients with hepatic metastases undergoing hepatic artery infusion chemotherapy?Hannah L Steinberg-Vorhoff, Saskia C Ting, Sebastian Zensen, et al.
Pageof 1